riluzole

Edaravon

Products For ALS treatment, edaravone was approved in Japan in 2015 (Radicut) and in the United States in 2017 as an infusion product (Radicava). In the EU, edaravone has orphan drug status. In many countries, the drug has been registered since 2019. Structure and properties Edaravone (C10H10N2O, Mr = 174.2 g/mol) is a substituted 2-pyrazolin-5-one. … Edaravon

Riluzole

Products Riluzole is commercially available in the form of film-coated tablets (Rilutek). It has been approved in many countries since 1996. In 2018, an additional oral suspension was registered (CH: Teglutik, USA: Tiglutik). Structure and properties Riluzole (C8H5F3N2OS, Mr = 234.2 g/mol) is a benzothiazole. It exists as a white to slightly yellow powder that … Riluzole